{{Rsnum
|rsid=2234951
|Gene=GSTA2
|Chromosome=6
|position=52752940
|Orientation=minus
|GMAF=0.05693
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=GSTA2
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 89.1 | 10.9 | 0.0
| HCB | 75.0 | 25.0 | 0.0
| JPT | 74.5 | 25.5 | 0.0
| YRI | 100.0 | 0.0 | 0.0
| ASW | 92.9 | 7.1 | 0.0
| CHB | 75.0 | 25.0 | 0.0
| CHD | 84.1 | 15.0 | 0.9
| GIH | 86.7 | 13.3 | 0.0
| LWK | 98.2 | 1.8 | 0.0
| MEX | 96.4 | 3.6 | 0.0
| MKK | 99.4 | 0.6 | 0.0
| TSI | 95.0 | 5.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=19639209
|Title=The role of GSTA2 polymorphisms and haplotypes in breast cancer susceptibility: a case-control study in the Portuguese population
}}

{{GET Evidence
|gene=GSTA2
|aa_change=Pro110Ser
|aa_change_short=P110S
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs2234951
|overall_frequency_n=276
|overall_frequency_d=10758
|overall_frequency=0.0256553
|n_genomes=4
|n_genomes_annotated=0
|n_haplomes=4
|n_articles=0
|n_articles_annotated=0
|pph2_score=0.003
|nblosum100=3
|autoscore=0
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}